Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Implant Sciences to raise $8.5 million in IPO (initial public offering):

This article was originally published in Clinica

Executive Summary

Implant Sciences, which is developing radioactive prostate seeds and coronary stents, plans to raise up to $8.5 million in an initial public offering on the Nasdaq SmallCap market and the Boston stock exchange. The Wakefield, Massachusetts-based company is to offer one million units - each one comprising one share of common stock and one redeemable common stock purchase warrant - for between $7 and $8.50 each. The company is also developing engineered surfaces for interventional cardiology devices (radiopaque stents, guidewires and catheters).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT077609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel